We are live on ! Find out more
GOSS icon

Gossamer Bio

110 hedge funds and large institutions have $684M invested in Gossamer Bio in 2020 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 13 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

354% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 13

164% more call options, than puts

Call options by funds: $1.79M | Put options by funds: $678K

100% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 14

67% more capital invested

Capital invested by funds: $410M → $684M (+$273M)

15% more funds holding

Funds holding: 96110 (+14)

8.33% more ownership

Funds ownership: 60.95%69.28% (+8.3%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
110
Holders Change
+14
Holders Change %
+14.58%
% of All Funds
2.26%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
28
Increased
59
Reduced
13
Closed
14
Calls
$1.79M
Puts
$678K
Net Calls
+$1.11M
Net Calls Change
+$3.69M
Name Holding Trade Value Shares
Change
Change in
Stake
Capital World Investors
26
Capital World Investors
California
$4.06M
Two Sigma Investments
27
Two Sigma Investments
New York
$3.81M +$3.34M +265,553 +967%
IHAM
28
Integral Health Asset Management
New York
$3.51M +$3.4M +270,000 New
Hudson Bay Capital Management
29
Hudson Bay Capital Management
Connecticut
$3.44M +$3.33M +265,000 New
Jacobs Levy Equity Management
30
Jacobs Levy Equity Management
New Jersey
$3.42M +$2.14M +170,045 +183%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.88M +$577K +45,911 +26%
PAI
32
Palo Alto Investors
California
$2.65M +$2.57M +204,214 New
Millennium Management
33
Millennium Management
New York
$2.59M +$985K +78,324 +65%
Ensign Peak Advisors
34
Ensign Peak Advisors
Utah
$2.53M -$154K -12,237 -6%
N
35
Nuveen
North Carolina
$2.45M -$67K -5,331 -3%
Goldman Sachs
36
Goldman Sachs
New York
$2.25M +$1.25M +99,005 +133%
Swiss National Bank
37
Swiss National Bank
Switzerland
$1.53M +$1.01M +80,000 +211%
Fidelity Investments
38
Fidelity Investments
Massachusetts
$1.49M -$482K -38,300 -25%
AA
39
ALPS Advisors
Colorado
$1.34M -$210K -16,701 -14%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.3M +$61.3K +4,877 +5%
FCM
41
Farallon Capital Management
California
$1.3M
Prudential Financial
42
Prudential Financial
New Jersey
$1.1M +$517K +41,143 +95%
PCM
43
Pinz Capital Management
New York
$1.1M +$1.06M +84,300 New
CS
44
Credit Suisse
Switzerland
$1.08M +$541K +42,993 +108%
Arrowstreet Capital
45
Arrowstreet Capital
Massachusetts
$1.04M +$848K +67,428 +535%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$1.01M +$224K +17,786 +29%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$972K +$111K +8,835 +13%
Russell Investments Group
48
Russell Investments Group
United Kingdom
$900K +$812K +64,580 +1,340%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$890K +$28.9K +2,300 +3%
BFM
50
Boothbay Fund Management
New York
$776K +$751K +59,723 New

GOSS Hedge Fund Activity: Q2 2020 in Review

110 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q2 2020, worth a combined $684M — up 67% from $410M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new GOSS positions and 14 closed out — a net gain of 14 holders — while 59 added to existing stakes and 13 trimmed.

The largest buyer was Capital International Investors, adding an estimated $23.7M. The largest seller was Victory Capital Management, cutting an estimated $16.5M.

  • 110 institutional investors held Gossamer Bio (GOSS) as of Q2 2020, up from 96 in Q1 2020.
  • Funds reported $684M of Gossamer Bio stock for Q2 2020, up 67% quarter-over-quarter.
  • 28 funds opened new Gossamer Bio positions in Q2 2020 and 14 closed out, a net change of +14 holders.
  • The largest Gossamer Bio buyer in Q2 2020 was Capital International Investors, an estimated $23.7M added.
  • The largest Gossamer Bio seller in Q2 2020 was Victory Capital Management, an estimated $16.5M sold.

Based on aggregated 13F filings for Q2 2020.